Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 19

1.

Sex differences in cognitive impairment in Alzheimer's disease.

Laws KR, Irvine K, Gale TM.

World J Psychiatry. 2016 Mar 22;6(1):54-65. doi: 10.5498/wjp.v6.i1.54. eCollection 2016 Mar 22. Review.

2.

Precortical Phase of Alzheimer's Disease (AD)-Related Tau Cytoskeletal Pathology.

Stratmann K, Heinsen H, Korf HW, Del Turco D, Ghebremedhin E, Seidel K, Bouzrou M, Grinberg LT, Bohl J, Wharton SB, den Dunnen W, Rüb U.

Brain Pathol. 2016 May;26(3):371-86. doi: 10.1111/bpa.12289. Epub 2015 Aug 24.

3.

PART, a distinct tauopathy, different from classical sporadic Alzheimer disease.

Jellinger KA, Alafuzoff I, Attems J, Beach TG, Cairns NJ, Crary JF, Dickson DW, Hof PR, Hyman BT, Jack CR Jr, Jicha GA, Knopman DS, Kovacs GG, Mackenzie IR, Masliah E, Montine TJ, Nelson PT, Schmitt F, Schneider JA, Serrano-Pozo A, Thal DR, Toledo JB, Trojanowski JQ, Troncoso JC, Vonsattel JP, Wisniewski T.

Acta Neuropathol. 2015 May;129(5):757-62. doi: 10.1007/s00401-015-1407-2. Epub 2015 Mar 17. No abstract available.

4.

Amyloid and APOE ε4 interact to influence short-term decline in preclinical Alzheimer disease.

Mormino EC, Betensky RA, Hedden T, Schultz AP, Ward A, Huijbers W, Rentz DM, Johnson KA, Sperling RA; Alzheimer's Disease Neuroimaging Initiative; Australian Imaging Biomarkers and Lifestyle Flagship Study of Ageing; Harvard Aging Brain Study.

Neurology. 2014 May 20;82(20):1760-7. doi: 10.1212/WNL.0000000000000431. Epub 2014 Apr 18.

5.

Apolipoprotein E gene polymorphism and Alzheimer's disease in Chinese population: a meta-analysis.

Liu M, Bian C, Zhang J, Wen F.

Sci Rep. 2014 Mar 17;4:4383. doi: 10.1038/srep04383.

6.

A combined effect of two Alzheimer's risk genes on medial temporal activity during executive attention in young adults.

Green AE, Gray JR, Deyoung CG, Mhyre TR, Padilla R, Dibattista AM, William Rebeck G.

Neuropsychologia. 2014 Apr;56:1-8. doi: 10.1016/j.neuropsychologia.2013.12.020. Epub 2014 Jan 2.

7.

Apolipoprotein E, gender, and Alzheimer's disease: an overlooked, but potent and promising interaction.

Ungar L, Altmann A, Greicius MD.

Brain Imaging Behav. 2014 Jun;8(2):262-73. doi: 10.1007/s11682-013-9272-x. Review.

8.

Higher rates of decline for women and apolipoprotein E epsilon4 carriers.

Holland D, Desikan RS, Dale AM, McEvoy LK; Alzheimer's Disease Neuroimaging Initiative.

AJNR Am J Neuroradiol. 2013 Dec;34(12):2287-93. doi: 10.3174/ajnr.A3601. Epub 2013 Jul 4. Erratum in: AJNR Am J Neuroradiol. 2015 Oct;36(10):E67.

9.

Apolipoprotein E genotype, dementia, and mortality in the oldest old: the 90+ Study.

Corrada MM, Paganini-Hill A, Berlau DJ, Kawas CH.

Alzheimers Dement. 2013 Jan;9(1):12-8. doi: 10.1016/j.jalz.2011.12.004. Epub 2012 Nov 2.

10.

CLU, CR1 and PICALM genes associate with Alzheimer's-related senile plaques.

Kok EH, Luoto T, Haikonen S, Goebeler S, Haapasalo H, Karhunen PJ.

Alzheimers Res Ther. 2011 Apr 5;3(2):12. doi: 10.1186/alzrt71.

11.

Reduced physiological complexity in robust elderly adults with the APOE epsilon4 allele.

Cheng D, Tsai SJ, Hong CJ, Yang AC.

PLoS One. 2009 Nov 5;4(11):e7733. doi: 10.1371/journal.pone.0007733.

12.

Influence of cognitive status, age, and APOE-4 genetic risk on brain FDDNP positron-emission tomography imaging in persons without dementia.

Small GW, Siddarth P, Burggren AC, Kepe V, Ercoli LM, Miller KJ, Lavretsky H, Thompson PM, Cole GM, Huang SC, Phelps ME, Bookheimer SY, Barrio JR.

Arch Gen Psychiatry. 2009 Jan;66(1):81-7. doi: 10.1001/archgenpsychiatry.2008.516.

13.

The influence of parental history of Alzheimer's disease and apolipoprotein E epsilon4 on the BOLD signal during recognition memory.

Xu G, McLaren DG, Ries ML, Fitzgerald ME, Bendlin BB, Rowley HA, Sager MA, Atwood C, Asthana S, Johnson SC.

Brain. 2009 Feb;132(Pt 2):383-91. doi: 10.1093/brain/awn254. Epub 2008 Oct 1.

14.

Parenchymal and vascular Abeta-deposition and its effects on the degeneration of neurons and cognition in Alzheimer's disease.

Thal DR, Griffin WS, Braak H.

J Cell Mol Med. 2008 Oct;12(5B):1848-62. doi: 10.1111/j.1582-4934.2008.00411.x. Epub 2008 Jul 10. Review.

15.

A luteinizing hormone receptor intronic variant is significantly associated with decreased risk of Alzheimer's disease in males carrying an apolipoprotein E epsilon4 allele.

Haasl RJ, Ahmadi MR, Meethal SV, Gleason CE, Johnson SC, Asthana S, Bowen RL, Atwood CS.

BMC Med Genet. 2008 Apr 25;9:37. doi: 10.1186/1471-2350-9-37.

16.

The influence of Alzheimer disease family history and apolipoprotein E epsilon4 on mesial temporal lobe activation.

Johnson SC, Schmitz TW, Trivedi MA, Ries ML, Torgerson BM, Carlsson CM, Asthana S, Hermann BP, Sager MA.

J Neurosci. 2006 May 31;26(22):6069-76.

17.

Very early detection of Alzheimer neuropathology and the role of brain reserve in modifying its clinical expression.

Mortimer JA, Borenstein AR, Gosche KM, Snowdon DA.

J Geriatr Psychiatry Neurol. 2005 Dec;18(4):218-23. Review.

18.

Amyloid mediates the association of apolipoprotein E e4 allele to cognitive function in older people.

Bennett DA, Schneider JA, Wilson RS, Bienias JL, Berry-Kravis E, Arnold SE.

J Neurol Neurosurg Psychiatry. 2005 Sep;76(9):1194-9.

19.

Risk and protective effects of the APOE gene towards Alzheimer's disease in the Kungsholmen project: variation by age and sex.

Qiu C, Kivipelto M, Agüero-Torres H, Winblad B, Fratiglioni L.

J Neurol Neurosurg Psychiatry. 2004 Jun;75(6):828-33.

Supplemental Content

Support Center